Cargando…

Prognostic Utility of Multivariate Morphometry in Schizophrenia

Background: Voxel-based morphometry studies have repeatedly highlighted the presence of distributed gray matter changes in schizophrenia, but to date, it is not clear if clinically useful prognostic information can be gleaned from structural imaging. The suspected association between gray matter vol...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Mingli, Li, Xiaojing, Das, Tushar Kanti, Deng, Wei, Li, Yinfei, Zhao, Liansheng, Ma, Xiaohong, Wang, Yingcheng, Yu, Hua, Meng, Yajing, Wang, Qiang, Palaniyappan, Lena, Li, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476259/
https://www.ncbi.nlm.nih.gov/pubmed/31037060
http://dx.doi.org/10.3389/fpsyt.2019.00245
_version_ 1783412876288983040
author Li, Mingli
Li, Xiaojing
Das, Tushar Kanti
Deng, Wei
Li, Yinfei
Zhao, Liansheng
Ma, Xiaohong
Wang, Yingcheng
Yu, Hua
Meng, Yajing
Wang, Qiang
Palaniyappan, Lena
Li, Tao
author_facet Li, Mingli
Li, Xiaojing
Das, Tushar Kanti
Deng, Wei
Li, Yinfei
Zhao, Liansheng
Ma, Xiaohong
Wang, Yingcheng
Yu, Hua
Meng, Yajing
Wang, Qiang
Palaniyappan, Lena
Li, Tao
author_sort Li, Mingli
collection PubMed
description Background: Voxel-based morphometry studies have repeatedly highlighted the presence of distributed gray matter changes in schizophrenia, but to date, it is not clear if clinically useful prognostic information can be gleaned from structural imaging. The suspected association between gray matter volume (GMV) and duration of psychotic illness, antipsychotic exposure, and symptom severity also limits the prognostic utility of morphometry. We address the question of whether morphometric information from patients with drug-naive first-episode psychosis can predict the linear trajectory of symptoms following early antipsychotic intervention using a longitudinal design. Method: Sixty-two first-episode, drug-naive patients with schizophrenia underwent brain magnetic resonance imaging scans at baseline, treated with antipsychotics, and rescanned after 1-year follow-up. Positive and Negative Syndrome Scale (PANSS) was used to assess their clinical manifestations. A multivariate approach to detect covariance-based network-like spatial components [Source Based Morphometry (SBM)] was performed to analyze the GMV. Paired t tests were used to study changes in the loading coefficients of GMV in the spatial components between two time points. The reduction in PANSS scores between the baseline (T0) and 1-year follow-up (T1) expressed as a ratio of the baseline scores (reduction ratio) was computed for positive, negative, and disorganization symptoms. Separate multiple regression analyses were conducted to predict the longitudinal change in symptoms (treatment response) using the loading coefficients of spatial components that differed between T0 and T1 with age, gender, duration of illness, and antipsychotic dose as covariates. We also tested the putative “toxicity” effects of baseline symptom severity on the GMV at 1 year using multiple regression analysis. Results: Of the 30 spatial components of gray matter extracted using SBM, loading coefficients of anterior cingulate cortex (ACC), insula and inferior frontal gyrus (IFG), superior temporal gyrus (STG), middle temporal gyrus (MTG), precuenus, and dorsolateral prefrontal cortex (DLPFC) reduced with time in patients. Specifically, the lower volume of insula and IFG at baseline predicted a lack of improvement in positive and disorganization symptoms. None of the symptom severity scores (positive, negative, or disorganization) at baseline independently predicted the reduced GMV at 1 year. Conclusions: The baseline deficit in a covariance-based network-like spatial component comprising of insula and IFG is predictive of the clinical course of schizophrenia. We do not find any evidence to support the notion of symptoms per se being neurotoxic to gray matter tissue. If judiciously combined with other available predictors of clinical outcome, multivariate morphometric information can improve our ability to predict prognosis in schizophrenia.
format Online
Article
Text
id pubmed-6476259
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-64762592019-04-29 Prognostic Utility of Multivariate Morphometry in Schizophrenia Li, Mingli Li, Xiaojing Das, Tushar Kanti Deng, Wei Li, Yinfei Zhao, Liansheng Ma, Xiaohong Wang, Yingcheng Yu, Hua Meng, Yajing Wang, Qiang Palaniyappan, Lena Li, Tao Front Psychiatry Psychiatry Background: Voxel-based morphometry studies have repeatedly highlighted the presence of distributed gray matter changes in schizophrenia, but to date, it is not clear if clinically useful prognostic information can be gleaned from structural imaging. The suspected association between gray matter volume (GMV) and duration of psychotic illness, antipsychotic exposure, and symptom severity also limits the prognostic utility of morphometry. We address the question of whether morphometric information from patients with drug-naive first-episode psychosis can predict the linear trajectory of symptoms following early antipsychotic intervention using a longitudinal design. Method: Sixty-two first-episode, drug-naive patients with schizophrenia underwent brain magnetic resonance imaging scans at baseline, treated with antipsychotics, and rescanned after 1-year follow-up. Positive and Negative Syndrome Scale (PANSS) was used to assess their clinical manifestations. A multivariate approach to detect covariance-based network-like spatial components [Source Based Morphometry (SBM)] was performed to analyze the GMV. Paired t tests were used to study changes in the loading coefficients of GMV in the spatial components between two time points. The reduction in PANSS scores between the baseline (T0) and 1-year follow-up (T1) expressed as a ratio of the baseline scores (reduction ratio) was computed for positive, negative, and disorganization symptoms. Separate multiple regression analyses were conducted to predict the longitudinal change in symptoms (treatment response) using the loading coefficients of spatial components that differed between T0 and T1 with age, gender, duration of illness, and antipsychotic dose as covariates. We also tested the putative “toxicity” effects of baseline symptom severity on the GMV at 1 year using multiple regression analysis. Results: Of the 30 spatial components of gray matter extracted using SBM, loading coefficients of anterior cingulate cortex (ACC), insula and inferior frontal gyrus (IFG), superior temporal gyrus (STG), middle temporal gyrus (MTG), precuenus, and dorsolateral prefrontal cortex (DLPFC) reduced with time in patients. Specifically, the lower volume of insula and IFG at baseline predicted a lack of improvement in positive and disorganization symptoms. None of the symptom severity scores (positive, negative, or disorganization) at baseline independently predicted the reduced GMV at 1 year. Conclusions: The baseline deficit in a covariance-based network-like spatial component comprising of insula and IFG is predictive of the clinical course of schizophrenia. We do not find any evidence to support the notion of symptoms per se being neurotoxic to gray matter tissue. If judiciously combined with other available predictors of clinical outcome, multivariate morphometric information can improve our ability to predict prognosis in schizophrenia. Frontiers Media S.A. 2019-04-15 /pmc/articles/PMC6476259/ /pubmed/31037060 http://dx.doi.org/10.3389/fpsyt.2019.00245 Text en Copyright © 2019 Li, Li, Das, Deng, Li, Zhao, Ma, Wang, Yu, Meng, Wang, Palaniyappan and Li http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Li, Mingli
Li, Xiaojing
Das, Tushar Kanti
Deng, Wei
Li, Yinfei
Zhao, Liansheng
Ma, Xiaohong
Wang, Yingcheng
Yu, Hua
Meng, Yajing
Wang, Qiang
Palaniyappan, Lena
Li, Tao
Prognostic Utility of Multivariate Morphometry in Schizophrenia
title Prognostic Utility of Multivariate Morphometry in Schizophrenia
title_full Prognostic Utility of Multivariate Morphometry in Schizophrenia
title_fullStr Prognostic Utility of Multivariate Morphometry in Schizophrenia
title_full_unstemmed Prognostic Utility of Multivariate Morphometry in Schizophrenia
title_short Prognostic Utility of Multivariate Morphometry in Schizophrenia
title_sort prognostic utility of multivariate morphometry in schizophrenia
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476259/
https://www.ncbi.nlm.nih.gov/pubmed/31037060
http://dx.doi.org/10.3389/fpsyt.2019.00245
work_keys_str_mv AT limingli prognosticutilityofmultivariatemorphometryinschizophrenia
AT lixiaojing prognosticutilityofmultivariatemorphometryinschizophrenia
AT dastusharkanti prognosticutilityofmultivariatemorphometryinschizophrenia
AT dengwei prognosticutilityofmultivariatemorphometryinschizophrenia
AT liyinfei prognosticutilityofmultivariatemorphometryinschizophrenia
AT zhaoliansheng prognosticutilityofmultivariatemorphometryinschizophrenia
AT maxiaohong prognosticutilityofmultivariatemorphometryinschizophrenia
AT wangyingcheng prognosticutilityofmultivariatemorphometryinschizophrenia
AT yuhua prognosticutilityofmultivariatemorphometryinschizophrenia
AT mengyajing prognosticutilityofmultivariatemorphometryinschizophrenia
AT wangqiang prognosticutilityofmultivariatemorphometryinschizophrenia
AT palaniyappanlena prognosticutilityofmultivariatemorphometryinschizophrenia
AT litao prognosticutilityofmultivariatemorphometryinschizophrenia